معرفی
Professeure associée at Université de Montréal in the Department of Chemistry (Faculty of Arts and Sciences) and affiliated with the Department of Pharmacology and Physiology (Faculty of Medicine). Her research focuses on medicinal chemistry, designing novel chemical entities for cancer therapy. Holds dual academic appointments and leads drug discovery initiatives at IRIC. Completed a PhD at Université de Sherbrooke (1990), followed by postdoctoral work at Washington University School of Medicine. Extensive industry experience with Bristol-Myers Squibb (1991–2007) before joining IRIC.
- Key affiliations: IRIC, GRUM, RQRM
- Research projects: Over 30 funded projects including ERK3/ERK4 inhibitors, DNA-encoded libraries, and AML treatment
Supervised 6+ students in recent years. Active in both basic and translational research with >100 publications. Leads teams in chemogenomic profiling and drug repurposing strategies targeting leukemia vulnerabilities.
